"Eosine Yellowish-(YS)" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A versatile red dye used in cosmetics, pharmaceuticals, textiles, etc., and as tissue stain, vital stain, and counterstain with HEMATOXYLIN. It is also used in special culture media.
| Descriptor ID |
D004801
|
| MeSH Number(s) |
D02.455.426.779.347.325 D03.633.300.953.275.325 D04.711.347.325
|
| Concept/Terms |
Eosine Yellowish-(YS)- Eosine Yellowish-(YS)
- Eosine Yellowish
- Tetrabromofluorescein
- Acid Red 87
- Eosin Y
- Eosine
- C.I. Acid Red 87
- Eosin
|
Below are MeSH descriptors whose meaning is more general than "Eosine Yellowish-(YS)".
Below are MeSH descriptors whose meaning is more specific than "Eosine Yellowish-(YS)".
This graph shows the total number of publications written about "Eosine Yellowish-(YS)" by people in this website by year, and whether "Eosine Yellowish-(YS)" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1992 | 0 | 2 | 2 |
| 1993 | 1 | 1 | 2 |
| 1994 | 0 | 1 | 1 |
| 1995 | 1 | 1 | 2 |
| 1996 | 1 | 3 | 4 |
| 1997 | 1 | 3 | 4 |
| 1998 | 0 | 6 | 6 |
| 2000 | 0 | 4 | 4 |
| 2001 | 0 | 2 | 2 |
| 2002 | 1 | 6 | 7 |
| 2003 | 2 | 8 | 10 |
| 2004 | 2 | 13 | 15 |
| 2005 | 1 | 13 | 14 |
| 2006 | 3 | 3 | 6 |
| 2007 | 2 | 6 | 8 |
| 2008 | 6 | 20 | 26 |
| 2009 | 3 | 17 | 20 |
| 2010 | 3 | 16 | 19 |
| 2011 | 1 | 19 | 20 |
| 2012 | 3 | 23 | 26 |
| 2013 | 8 | 17 | 25 |
| 2014 | 7 | 15 | 22 |
| 2015 | 9 | 10 | 19 |
| 2016 | 6 | 14 | 20 |
| 2017 | 2 | 6 | 8 |
| 2018 | 6 | 8 | 14 |
| 2019 | 1 | 4 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Eosine Yellowish-(YS)" by people in Profiles.
-
Development and Evaluation of a Novel Point-of-Use Quality Assurance Tool for Digital Pathology. Arch Pathol Lab Med. 2019 10; 143(10):1246-1255.
-
Visible-light activation of TiO2 by dye-sensitization for degradation of pharmaceutical compounds. Photochem Photobiol Sci. 2019 Apr 10; 18(4):897-904.
-
Antigens under cover-The preservation and demasking of selected antigens for successful poststaining immunocytochemistry of effusion, brain smears, and lymph node aspirates. Vet Clin Pathol. 2019 Oct; 48 Suppl 1:98-107.
-
AIM2 gene silencing attenuates diabetic cardiomyopathy in type 2 diabetic rat model. Life Sci. 2019 Mar 15; 221:249-258.
-
Tetrachromic VOF/Masson's trichrome/H and E stains: Unmasking their usability in differential stromal hard tissue staining. Indian J Pathol Microbiol. 2019 Jan-Mar; 62(1):67-72.
-
Eosin-5'-maleimide binding test-Do we use appropriate reference values to detect hereditary spherocytosis in neonates? Int J Lab Hematol. 2019 06; 41(3):e57-e60.
-
'Third Space' Perspective on Redefining Oral Pathology: Hypothetical Considerations. J Contemp Dent Pract. 2018 Nov 01; 19(11):1293-1294.
-
Hematoxylin and eosin staining of intact tissues via delipidation and ultrasound. Sci Rep. 2018 08 16; 8(1):12259.
-
Eosin treatment for psoriasis reduces skin leukocyte infiltration and secretion of inflammatory chemokines and angiogenic factors. Eur J Dermatol. 2018 Aug 01; 28(4):457-466.
-
Comparing Immunofluorescent versus H&E Glandular Architecture Features in Prognostic Models from Prostate Biopsies. Annu Int Conf IEEE Eng Med Biol Soc. 2018 Jul; 2018:838-841.